Appropriate Use of Inpatient Erythropoiesis Stimulating Agents
Background: Anemia is a significant global public health issue, and it is associated with lethargy, weakness, tiredness, and shortness of breath. Erythropoietin stimulating agents (ESAs) are recombinant / synthetic erythropoietin and can increase hemoglobin (Hb) levels. There are increased risks of...
Saved in:
Main Authors: | Chenghao Cui, Timothy Nguyen, Mohammad Rattu |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Minnesota Libraries Publishing
2024-11-01
|
Series: | INNOVATIONS in Pharmacy |
Subjects: | |
Online Access: | https://pubs.lib.umn.edu/index.php/innovations/article/view/6284 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lower serum magnesium level is an important risk factor for erythropoiesis-stimulating agents hypo-responsiveness in hemodialysis patients
by: Hayam Hebah, et al.
Published: (2025-02-01) -
Overview of preclinical and phase II clinical studies on Pegmolesatide’s long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction
by: Xiaoying Ma, et al.
Published: (2025-02-01) -
Luteal Phase Stimulation in the Same Cycle Is an Effective Strategy to Rescue POSEIDON Poor Responders with No Embryos after the First Follicular Stimulation
by: Abha Majumdar, et al.
Published: (2023-07-01) -
Home-based transcranial direct current stimulation paired with cognitive training to reduce fatigue in multiple sclerosis
by: Leigh Charvet, et al.
Published: (2025-02-01) -
Repetitive transcranial magnetic stimulation as a modality of treatment in patients with fibromyalgia
by: Rawan M. El Shahat, et al.
Published: (2025-02-01)